RK Strategies, Inc. lobbying for Nexalin Technology Inc.

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

H.R.3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 H.R. 7091, Expanding Veterans Access to Emerging Treatments Act Authorizing legislation around neurostimulation Appropriations issues

Defense

H.R.3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 H.R. 7091, Expanding Veterans Access to Emerging Treatments Act Authorizing legislation around neurostimulation Appropriations issues

Veterans

H.R.3838, Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 H.R. 7091, Expanding Veterans Access to Emerging Treatments Act Authorizing legislation around neurostimulation Appropriations issues

Bills named in this filing 2

H.R. 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
H.R. 7091
Expanding Veterans’ Access to Emerging Treatments Act